Table 1 Anthropometric, nutritional and biochemical variables for total obese patients, and according to oxidized-LDL (Ox-LDL) levels (lower or higher than the median value observed for total patients, 39.2 U/l)
From: Bilirubin is independently associated with oxidized LDL levels in young obese patients
All obese patients | Ox-LDL < 39.2 U/l | Ox-LDL ≥ 39.2 U/l | ||
|---|---|---|---|---|
(n = 125) | (n = 62) | (n = 63) | P a | |
Age (years) | 13.4 ± 1.9 | 13.3 ± 1.8 | 13.6 ± 1.9 | 0.351 |
Sex (females (%)) | 67 (53.6) | 35 (56.5) | 32 (50.8) | 0.592 |
Tanner (pre-pub (%)) | 9 (7.2) | 4 (6.5) | 5 (7.9) | 1.000 |
Height (cm) | 161.8 ± 9.0 | 162.4 ± 9.2 | 161.3 ± 8.8 | 0.490 |
Weight (Kg) | 89.3 ± 22.4 | 86.7 ± 18.9 | 91.9 ± 25.3 | 0.196 |
BMI (kg/m 2 ) | 33.7 ± 6.2 | 32.6 ± 4.9 | 34.9 ± 7.1 | 0.041 |
BMI z-score | 2.28 ± 0.32 | 2.24 ± 0.29 | 2.32 ± 0.36 | 0.150 |
Waist circumference (cm) | 104.9 ± 15.2 | 103.7 ± 13.3 | 105.9 ± 16.8 | 0.420 |
WtHr | 0.65 ± 0.08 | 0.64 ± 0.07 | 0.66 ± 0.09 | 0.227 |
TG (mg/dl) | 89.0 (60.0-119.5) | 66.0 (53.0-98.0) | 108.0 (85.0-135.0) | <0.001 |
Total cholesterol (mg/dl) | 150.0 (133.0-173.5) | 135.5 (117.8-155.3) | 163.0 (149.0-187.0) | <0.001 |
HDLc (mg/dl) | 40.0 (36.0-48.0) | 41.0 (37.0-49.3) | 40.0 (35.0-46.0) | 0.119 |
LDLc (mg/dl) | 89.0 (73.5-107.5) | 76.0 (65.0-87.3) | 105.0 (90.0-121.0) | <0.001 |
HDLc/Total cholesterol | 0.28 (0.24-0.33) | 0.33 (0.29-0.36) | 0.24 (0.21-0.26) | <0.001 |
Ox-LDL (U/l) | 39.2 (32.5-47.6) | 32.5 (28.5-36.4) | 47.5 (42.9-53.3) | |
Glucose (mg/dl) | 79.0 (74.0-85.5) | 78.0 (73.8-84.3) | 80.0 (74.0-86.0) | 0.233 |
Insulin (μU/ml) | 18.6 (13.8-26.9) | 17.7 (13.1-23.4) | 21.3 (14.4-29.6) | 0.149 |
HOMA IR | 3.58 (2.63-5.52) | 3.27 (2.56-4.47) | 3.91 (2.64-6.36) | 0.106 |
CRP (mg/l) | 1.83 (0.88-4.48) | 1.33 (0.66-3.58) | 2.86 (1.04-5.03) | 0.004 |
Adiponectin (μg/ml) | 5.14 (3.59-7.04) | 4.77 (3.38-7.02) | 5.28 (3.91-7.12) | 0.174 |
Total bilirubin (μmol/l) | 10.60 (9.06-15.39) | 11.97 (9.92-18.47) | 9.92 (7.18-14.02) | 0.001 |